Optimizing cerebral perfusion and hemodynamics during cardiopulmonary bypass through cannula design combining in

Kristin Hugenroth1,2, Ralf Borchardt3, Philine Ritter3

  • 1Department of Cardiovascular Engineering, Institute of Applied Medical Engineering, Faculty of Medicine, RWTH Aachen University, Aachen, Germany. hugenroth@ame.rwth-aachen.de.

Scientific Reports
|August 19, 2021
PubMed

Insights

New aortic cannula designs (optiCAN and opti²CAN) significantly improve cerebral perfusion and reduce neurological complication risks during cardiopulmonary bypass (CPB) surgery. These innovations aim to decrease stroke incidence in high-risk patients undergoing cardiac procedures.

Area of Science:

  • Biomedical Engineering
  • Cardiovascular Surgery
  • Medical Device Design

Background:

  • Cardiopulmonary bypass (CPB) is essential for cardiac surgery but carries risks of neurological complications like stroke due to embolisms and reduced cerebral blood flow.
  • Current aortic cannulas may contribute to these complications by causing suboptimal aortic root washout and high wall shear stress.

Purpose of the Study:

  • To develop and evaluate novel aortic cannula designs aimed at mitigating neurological risks associated with CPB.
  • To enhance cerebral perfusion and reduce embolic events during cardiopulmonary bypass procedures.

Main Methods:

  • Design and in vivo testing of an optiCAN prototype with helical outflow and jet-splitting dispersion.
  • In vitro assessment of pressure loss and hemolysis.
  • In silico computational fluid dynamics (CFD) simulations of cannula performance in a human aortic model.
  • Development of a second-generation design (opti²CAN) based on CFD findings.

Main Results:

  • The optiCAN prototype restored cerebral perfusion to 97.5% of physiological flow in vivo, compared to 74.6% for a commercial cannula.
  • optiCAN demonstrated unaffected pressure loss and hemolysis in vitro.
  • CFD simulations confirmed improved aortic root washout with optiCAN, reducing thromboembolism risk.
  • CFD identified high wall shear stress regions linked to plaque rupture risk, informing the opti²CAN design.

Conclusions:

  • Novel aortic cannula designs, optiCAN and opti²CAN, show significant potential to reduce neurological complications and stroke prevalence after CPB.
  • These designs offer improved cerebral perfusion, better aortic root washout, and optimized hemodynamics, particularly beneficial for high-risk patients.
  • The study highlights the value of integrated in vivo, in vitro, and in silico methods for medical device innovation in cardiovascular surgery.

Related Concept Videos